Blood Test Predicts Pregnancy Due Date

A small study based on circulating RNA in the blood of moms-to-be describes a technique that could be used to help predict who’s most at risk of preterm labor.

kerry grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, JACOBLUNDIn a study of 31 expectant mothers, researchers were able to accurately peg their due dates roughly half the time by sequencing nine types of circulating RNA in the blood. The test was about as reliable as using ultrasound, currently the go-to method of establishing a due date. The method, described today (June 7) in Science, also enabled the researchers to predict, in most cases, which of the high-risk pregnancies would end prematurely.

“Obviously the numbers [of participants] are very small but the results are very impressive,” Andrew Shennan, an obstetrics professor at St. Thomas’ Hospital in London who was not involved in the study, tells The Guardian. He adds that such a blood test would be especially useful in developing countries where ultrasound is not readily available.

The study to predict women’s due dates included expectant mothers in Denmark who submitted a blood sample each week throughout their pregnancies. The researchers zeroed in on nine transcripts known to originate in the placenta whose levels corresponded with pregnancy progression. Using these to predict the women’s due dates, the researchers got within 14 days 45 percent of the time. Ultrasound does the same 48 percent of the time, according ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo